Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma
Open Access
- 1 January 2017
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 9 (6) , 300-309
Abstract
Combined hepatocellular-cholangiocarcinoma (CHC) is a rare tumor with poor prognosis, with incidence ranging from 1.0%-4.7% of all primary hepatic tumors. This entity will be soon renamed as hepato-cholangiocarcinoma. The known risk factors for hepatocellular carcinoma (HCC) have been implicated for CHC including viral hepatitis and cirrhosis. It is difficult to diagnose this tumor pre-operatively. The predominant histologic component within the tumor largely determines the predominant radiographic features making it a difficult distinction. Heterogeneous and overlapping imaging features of HCC and cholangiocarcinoma should raise the suspicion for CHC and multiple core biopsies (from different areas of tumor) are recommended before administering treatment. Serum tumor markers CA19-9 and alpha-fetoprotein can aid in the diagnosis, but it remains a challenging diagnosis prior to resection. There is sufficient data to support bipotent hepatic progenitor cells as the cell of origin for CHC. The current World Health Organization classification categorizes two main types of CHC based on histo-morphological features: Classical type and CHC with stem cell features. Liver transplant is one of the available treatment modalities with other management options including transarterial chemoembolization, radiofrequency ablation, and percutaneous ethanol injection. We present a review paper on CHC highlighting the risk factors, origin, histological classification and therapeutic modalities.Keywords
This publication has 58 references indexed in Scilit:
- Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaJournal of Gastrointestinal Surgery, 2015
- Comparison of clinical characteristics of combined hepatocellular‐cholangiocarcinoma and other primary liver cancersJournal of Gastroenterology and Hepatology, 2012
- Pathology of combined hepatocellular‐cholangiocarcinomaJournal of Gastroenterology and Hepatology, 2010
- Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma: A Western ExperienceAnnals of Surgical Oncology, 2008
- Comparison of Combined Hepatocellular and Cholangiocarcinoma with Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaSurgery Today, 2006
- Combined Hepatocellular and Cholangiocarcinoma: a Clinicopathologic Study of 26 Resected CasesJapanese Journal of Clinical Oncology, 2003
- Hepatic Resection for Combined Hepatocellular and CholangiocarcinomaArchives of Surgery, 2003
- Natural history of hepatocellular carcinoma including fibrolamellar and hepato‐cholangiocarcinoma variantsJournal of Gastroenterology and Hepatology, 2002
- Combined hepatocellular and cholangiocarcinomaCancer, 2002
- COMBINED LIVER CELL AND BILE DUCT CARCINOMA1949